Clinical Research can now be Truly Patient-Centric by Quantifying Patient Burden with Medidata
NEW YORK, June 25, 2018 - To make clinical research truly patient-centric, Medidata (NASDAQ: MDSO) announced the launch of the Patient Burden Index (PBI) on the Medidata Cloud, the Intelligent Platform for Life Sciences. PBI empowers sponsors and CROs to identify and address high-burden procedures and visits that can impact patient participation and retention in a clinical trial.
Medidata built a unique analytical approach to patient centricity, solving complex study design and burdensome procedures that currently lead to high patient dropout, execution challenges and struggling investigators. The dropout rate for a clinical study today is often very substantial, sometimes more than 30%.1 A recent Medidata white paper outlines how incorporating factors such as patient pain, anxiety, hospitalization, and other components of patient experience into the initial trial design is instrumental to a study’s success.
To address today’s challenges, Medidata developed the Patient Burden Index, a component of the protocol optimization tool, Edge Design Optimizer, to improve visualization of the patient experience. PBI is built upon the industry’s largest pool of patient data, and the deep industry knowledge of data scientists, life science experts and developers at Medidata.
“Until now, assessing patient burden has largely been subjective. PBI is the first solution of its kind that uses a data-driven, objective approach to patient-centric trial design,” said Glen de Vries, co-founder and president, Medidata. “PBI empowers sponsors and CROs to address key challenges around study experience and patient retention.”
By communicating the potential hardship of patient procedures, sponsors and CROs can fine- tune protocol development and operational plans. Medidata identified eight risk components for researchers to address directly, including:
Anxiety-the level of anxiety caused by a procedure
Pain-the level of physical pain caused by a procedure
Invasiveness-a procedure’s level of physical invasiveness (e.g., blood draw; device
implantation)
PBI is a new feature within the Edge Trial Planning and Management family of clinical
operations solutions. Edge is one of three product families on Medidata’s unified platform, which are powering the digital transformation of the entire clinical trial process.
Medidata at DIA - Booth #1907: Visit Medidata at DIA this week, and discover new ways to power smarter trials and healthier people together. The company will host evocative thought leadership and partner presentations, live product demos, and much more throughout the three day event, including:
Medidata + SHYFT: The Intelligent Platform for Life Sciences - June 25, 4:45 PM EST
Data Driven Insights for Study Design and Operational Feasibility - June 26, 3:15 PM
EST
About Medidata
Medidata accelerates the digital transformation of life sciences through its unified platform, pioneering analytics, and unrivaled expertise. The Intelligent Platform for Life Sciences seamlessly delivers market-leading applications powered by artificial intelligence and real-world analytics to reduce risk, optimize revenue, and ultimately help patients.
More than 1,000 pharmaceutical companies, biotech, medical device firms, academic medical
centers and contract research organizations around the world can now manage and optimize value across the clinical and commercial continuum. For more information: www.mdsol.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
